Spontaneous internalization of IVIg in activated B cells

Immunology Letters

Volumn 124, Issue 1, 2009, Pages 18-26

  Proulx, Dominic Paquin ^a,b   Aubin, Éric ^a,b   Lemieux, Réal ^a,b   Bazin, Renée ^a,b  

^a Department of Research and Development ^*  (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

B cells; Intravenous immunoglobulins; Spontaneous internalization

Indexed keywords

B LYMPHOCYTE RECEPTOR; CELL PROTEIN; CELL SURFACE RECEPTOR; FC RECEPTOR; HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LYSOSOMAL TRAFFICKING REGULATOR PROTEIN; MEMBRANE RECEPTOR; NUCLEOLIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DRUG PENETRATION; DRUG TARGETING; FEMALE; HUMAN; HUMAN CELL; INTERNALIZATION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD40; B-LYMPHOCYTES; BIOLOGICAL TRANSPORT, ACTIVE; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOPRECIPITATION; LYMPHOCYTE ACTIVATION; MASS SPECTROMETRY; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, IGG;

EID: 67349214947     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.03.012     Document Type: Article

References (42)

1. Lemieux R., Bazin R., and Neron S. Therapeutic intravenous immunoglobulins. Mol Immunol 42 (2005) 839-848
2. Nimmerjahn F., and Ravetch J.V. Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol 26 (2008) 513-533
3. Bussel J.B. Fc receptor blockade and immune thrombocytopenic purpura. Semin Hematol 37 (2000) 261-266
4. Ott V.L., Fong D.C., and Cambier J.C. Fc gamma RIIB as a potential molecular target for intravenous gamma globulin therapy. J Allergy Clin Immunol 108 (2001) S95-S98
5. Lazarus A.H. Mechanism of action of IVIG in ITP. Vox Sang 83 Suppl 1 (2002) 53-55
6. Lemieux R., and Bazin R. Autoantibody-induced formation of immune complexes in normal human serum. Curr Pharm Des 12 (2006) 173-179
7. Aktas O., and Zipp F. Regulation of self-reactive T cells by human immunoglobulins-implications for multiple sclerosis therapy. Curr Pharm Des 9 (2003) 245-256
8. Kessel A., Ammuri H., Peri R., Pavlotzky E.R., Blank M., Shoenfeld Y., et al. Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function. J Immunol 179 (2007) 5571-5575
9. Bayry J., Lacroix-Desmazes S., Carbonneil C., Misra N., Donkova V., Pashov A., et al. Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood 101 (2003) 758-765
10. Sigman K., Ghibu F., Sommerville W., Toledano B.J., Bastein Y., Cameron L., et al. Intravenous immunoglobulin inhibits IgE production in human B lymphocytes. J Allergy Clin Immunol 102 (1998) 421-427
11. de Grandmont M.J., Racine C., Roy A., Lemieux R., and Neron S. Intravenous immunoglobulins induce the in vitro differentiation of human B lymphocytes and the secretion of IgG. Blood 101 (2003) 3065-3073
12. Zhuang Q., Bisotto S., Fixman E.D., and Mazer B. Suppression of IL-4- and CD40-induced B-lymphocyte activation by intravenous immunoglobulin is not mediated through the inhibitory IgG receptor FcgammaRIIb. J Allergy Clin Immunol 110 (2002) 480-483
13. Rabinovitch N., and Gelfand E.W. Expression of functional activating and inhibitory Fcgamma receptors on human B cells. Int Arch Allergy Immunol 133 (2004) 285-294
14. Roy A., Krzykwa E., Lemieux R., and Neron S. Increased efficiency of gamma-irradiated versus mitomycin C-treated feeder cells for the expansion of normal human cells in long-term cultures. J Hematother Stem Cell Res 10 (2001) 873-880
15. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
16. Ross J.A., Nagy Z.S., and Kirken R.A. The Phb1/2 phosphocomplex is required for mitochondrial homeostasis and survival of human T cells. J Biol Chem 283 (2008) 4699-4713
17. Bossi G., and Griffiths G.M. CTL secretory lysosomes: biogenesis and secretion of a harmful organelle. Semin Immunol 17 (2005) 87-94
18. Ugrinova I., Monier K., Ivaldi C., Thiry M., Storck S., Mongelard F., et al. Inactivation of nucleolin leads to nucleolar disruption, cell cycle arrest and defects in centrosome duplication. BMC Mol Biol 8 (2007) 66
19. Samuelsson A., Towers T.L., and Ravetch J.V. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291 (2001) 484-486
20. Crow A.R., Song S., Freedman J., Helgason C.D., Humphries R.K., Siminovitch K.A., et al. IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity. Blood 102 (2003) 558-560
21. Siragam V., Crow A.R., Brinc D., Song S., Freedman J., and Lazarus A.H. Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells. Nat Med 12 (2006) 688-692
22. Bruhns P., Samuelsson A., Pollard J.W., and Ravetch J.V. Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity 18 (2003) 573-581
23. Anthony R.M., Wermeling F., Karlsson M.C., and Ravetch J.V. Inaugural Article: identification of a receptor required for the anti-inflammatory activity of IVIG. Proc Natl Acad Sci U S A (2008)
24. Lapointe R., Bellemare-Pelletier A., Housseau F., Thibodeau J., and Hwu P. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Cancer Res 63 (2003) 2836-2843
25. Schaub A., Wymann S., Heller M., Ghielmetti M., Beleznay Z., Stadler B.M., et al. Self-reactivity in the dimeric intravenous immunoglobulin fraction. Ann N Y Acad Sci 1110 (2007) 681-693
26. Zhu X., Meng G., Dickinson B.L., Li X., Mizoguchi E., Miao L., et al. MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J Immunol 166 (2001) 3266-3276
27. Ronda N., Gatti R., Orlandini G., and Borghetti A. Binding and internalization of human IgG by living cultured endothelial cells. Clin Exp Immunol 109 (1997) 211-216
28. Carter S.D., Bacon P.A., and Hall N.D. Characterisation of activated lymphocytes in the peripheral blood of patients with rheumatoid arthritis. Ann Rheum Dis 40 (1981) 293-298
29. Ichikawa Y., Shimizu H., Yoshida M., and Arimori S. Activation antigens expressed on T-cells of the peripheral blood in Sjogren's syndrome and rheumatoid arthritis. Clin Exp Rheumatol 8 (1990) 243-249
30. Blum J.H., Stevens T.L., and DeFranco A.L. Role of the mu immunoglobulin heavy chain transmembrane and cytoplasmic domains in B cell antigen receptor expression and signal transduction. J Biol Chem 268 (1993) 27236-27245
31. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 15 (1997) 821-850
32. Tobian A.A., Harding C.V., and Canaday D.H. Mycobacterium tuberculosis heat shock fusion protein enhances class I MHC cross-processing and -presentation by B lymphocytes. J Immunol 174 (2005) 5209-5214
33. Faigle W., Raposo G., Tenza D., Pinet V., Vogt A.B., Kropshofer H., et al. Deficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: the Chediak-Higashi syndrome. J Cell Biol 141 (1998) 1121-1134
34. Vascotto F., Lankar D., Faure-Andre G., Vargas P., Diaz J., Le Roux D., et al. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation. J Cell Biol 176 (2007) 1007-1019
35. Binder R.J., Han D.K., and Srivastava P.K. CD91: a receptor for heat shock protein gp96. Nat Immunol 1 (2000) 151-155
36. Glebov O.O., Bright N.A., and Nichols B.J. Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nat Cell Biol 8 (2006) 46-54
37. Frances R., Tumang J.R., and Rothstein T.L. Extreme skewing of annexin II and S100A6 expression identified by proteomic analysis of peritoneal B-1 cells. Int Immunol 19 (2007) 59-65
38. Terashima M., Kim K.M., Adachi T., Nielsen P.J., Reth M., Kohler G., et al. The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein. EMBO J 13 (1994) 3782-3792
39. Wang S., Fusaro G., Padmanabhan J., and Chellappan S.P. Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression. Oncogene 21 (2002) 8388-8396
40. Mishra S., Murphy L.C., and Murphy L.J. The Prohibitins: emerging roles in diverse functions. J Cell Mol Med 10 (2006) 353-363
41. Baker M.A., Lane D.J., Ly J.D., De Pinto V., and Lawen A. VDAC1 is a transplasma membrane NADH-ferricyanide reductase. J Biol Chem 279 (2004) 4811-4819
42. Blachly-Dyson E., Zambronicz E.B., Yu W.H., Adams V., McCabe E.R., Adelman J., et al. Cloning and functional expression in yeast of two human isoforms of the outer mitochondrial membrane channel, the voltage-dependent anion channel. J Biol Chem 268 (1993) 1835-1841